Skip to main content

Table 4 Complications in death cases between MSC group and non-MSC group

From: Mesenchymal stromal cell treatment improves outcomes in children with pneumonia post-hematopoietic stem cell transplantation: a retrospective cohort study

  MSC Non-MSC p value
n (%) n (%)
Severe pneumonia 4 (100) 10 (100) 0.758
 Respiratory failure 4 (100) 10 (100)  
 GVHD 0 (0) 2 (20)  
 Organ failure 1 (25) 2 (20)  
 Septicemia 1 (25) 1 (10)  
 Secondary diabetes 1 (25) 0 (0)  
 Shock 0 (0) 3 (30)  
 Mediastinal emphysema 0 (0) 2(20)  
 Non-pulmonary inflammation 1 (25) 2 ( 20)